This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...
Honor Your StaffCelebrate Lab Week, and honor yourself and your colleagues as a vital part of the la...
The new online Learning Center with new content can still be found under the “Training” folder on ...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...
On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Da...
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...